Recurrent pregnancy loss

Reading File

Now let me search the medical library and PubMed in parallel.

Finding Sources

Searching PubMed

"recurrent pregnancy loss" AND management

Searching the Web

recurrent pregnancy loss causes investigation management 2024 guidelines

Good results. Now let me read the key textbook sections in parallel.

Reading File

Good content coming in. Let me read more of the Berek & Novak chapter and the Creasy & Resnik evaluation section.

Reading File

Excellent content. Let me now read more of the Berek chapter covering etiology details and management.

Reading File

I have rich content. Let me read the management/therapy section from Berek & Novak and the APS/immunologic section from Creasy & Resnik.

Reading File

I now have comprehensive content from both textbooks. Let me compile the full answer.

Recurrent Pregnancy Loss (RPL)

Definition

RPL is traditionally defined as 3 or more consecutive pregnancy losses before 20-24 weeks gestation. Many guidelines (ASRM, ESHRE) now justify evaluation after 2 losses, given that the prevalence of abnormal findings is similar after 2 or 3 miscarriages. RPL affects approximately 1% of couples attempting pregnancy. Sporadic (isolated) miscarriage is far more common, occurring in 15-25% of recognized pregnancies.

Etiology

1. Genetic Factors (most common cause of first-trimester loss)

Fetal aneuploidy - the single most common cause of sporadic miscarriage. As the number of losses increases, the proportion with a chromosomally abnormal conceptus decreases (from ~78% with 1 loss to ~18% with 7+ losses), meaning other etiologies become proportionally more important.
Parental chromosomal abnormalities - found in 3-5% of RPL couples vs. 0.2-0.7% of the general population. The most common is a balanced translocation (reciprocal 60%, Robertsonian 40%).
Polyploidy and uniparental disomy - detectable by SNP array but may be missed by standard G-banding or aCGH.

2. Anatomic Abnormalities (~15% of RPL)

Congenital Mullerian anomalies arise from failure of duct development, abnormal fusion, or failure of septal absorption:

Septate uterus - most common anomaly associated with RPL and most amenable to surgical correction (hysteroscopic metroplasty)
Bicornuate, unicornuate, and didelphic uteri
Acquired defects: submucosal fibroids, intrauterine adhesions (Asherman syndrome), endometrial polyps

Imaging: 3D transvaginal ultrasound is preferred (ESHRE); alternatives include sonohysterography, HSG, and MRI.

3. Antiphospholipid Syndrome (APS) - most treatable cause

APS is an acquired thrombophilia and the only immunologic cause with proven treatment. Diagnostic criteria require:

Clinical criteria: 1+ pregnancy loss at ≥10 weeks, 3+ losses before 10 weeks, or thrombosis
Laboratory criteria (must be positive on 2 occasions ≥12 weeks apart):
- Lupus anticoagulant (LA)
- Anticardiolipin antibodies (aCL) IgG/IgM
- Anti-β2-glycoprotein I (aβ2GPI) IgG/IgM

4. Endocrine Abnormalities

Disorder	Mechanism	Management
Hypothyroidism / subclinical hypothyroidism	Ovulatory and luteal phase dysfunction	Levothyroxine (especially if TSH >2.5 mIU/mL in pregnancy or TPO-Ab positive)
Thyroid peroxidase antibodies (euthyroid)	Marker of generalized autoimmunity; impairs thyroid response to pregnancy demands	Levothyroxine shown to reduce miscarriage in IVF patients
Hyperprolactinemia	Alters folliculogenesis, luteal phase; shortened luteal phase	Dopamine agonist (bromocriptine/cabergoline)
PCOS / insulin resistance	Elevated LH, androgen excess, insulin resistance; miscarriage rate ~50% in PCOS vs 15-20% general	Metformin may reduce miscarriage in insulin-resistant RPL women (small studies)
Diabetes mellitus	Hyperglycemia directly damages embryo; vascular compromise	Tight glycemic control

5. Thrombophilias (Inherited)

Factor V Leiden, Prothrombin gene mutation (G20210A), MTHFR mutations, Protein C/S deficiency, Antithrombin III deficiency
Evidence for routine screening is weak - inherited thrombophilias have a less established link to early RPL than to late fetal loss. ASRM does not recommend routine thrombophilia screening beyond APS.

6. Immunologic Factors

Cellular immunity: Altered NK cell function and Th1/Th2 imbalance have been proposed. A 2023 meta-analysis (PMID 37236061) confirmed elevated peripheral NK cell cytotoxicity in recurrent miscarriage.
Leukocyte immunization, IVIG, and paternal lymphocyte immunotherapy remain unproven and experimental.

7. Male Factors

Sperm DNA fragmentation and chromosomal abnormalities in sperm contribute to embryo aneuploidy and RPL.

8. Other/Environmental Factors

Obesity (BMI >25-30 independently increases risk)
Smoking, alcohol, caffeine (>200 mg/day)
Advanced maternal age (due to increased aneuploidy)
Uterine blood flow abnormalities

9. Unexplained RPL

Despite thorough evaluation, at least 50% of couples have no identifiable cause. This is not necessarily discouraging - even after several losses, the chance of a subsequent live birth exceeds the chance of another miscarriage in most age groups.

Evaluation

When to evaluate: After 2 or more losses (ASRM, ESHRE, and most current guidelines agree).

History

Number, timing (trimester), and characteristics of each loss
Subfertility, menstrual pattern, DES exposure, infections
Personal/family history of thrombosis, autoimmune disease
Medications, environmental/substance exposures
Consanguinity

Physical Examination

BMI, signs of PCOS (hirsutism, acanthosis nigricans)
Thyroid palpation
Galactorrhea
Pelvic exam (anatomy, estrogenization)

Recommended Laboratory and Imaging Tests

Category	Tests
Genetic	Parental peripheral blood karyotype (both partners); chromosomal microarray (CMA) on products of conception
Uterine	3D transvaginal ultrasound (preferred), sonohysterography, HSG, or MRI
APS/Autoimmune	Lupus anticoagulant; aCL IgG/IgM; aβ2GPI IgG/IgM
Endocrine	TSH (with TPO antibodies per ESHRE); prolactin; HbA1c; consider fasting glucose/insulin if PCOS suspected
Thrombophilia	Only if personal/family thrombotic history; not routine

Tests NOT routinely recommended

ANA, celiac markers, other autoantibodies
Ovarian reserve testing (AMH, FSH/E2) - not part of ASRM standard RPL work-up, though it may guide prognosis
Routine thrombophilia panel beyond APS

Management

Genetic Abnormalities

Parental balanced translocation: Genetic counseling; IVF with preimplantation genetic testing for structural rearrangements (PGT-SR) can improve live birth rates. A 2025 meta-analysis (PMID 39151684) found PGT for aneuploidy in unexplained RPL does not clearly improve live birth rates over expectant management in unselected patients.
Karyotype products of conception from subsequent losses to determine whether it is a "random" aneuploid event (somewhat reassuring) or euploid (indicating another etiology).

Anatomic Correction

Septate uterus: Hysteroscopic metroplasty is first-line; live birth rates improve significantly.
Submucosal fibroids / polyps: Hysteroscopic removal.
Intrauterine adhesions: Hysteroscopic lysis.

APS Treatment

Low-dose aspirin (75-81 mg/day) + unfractionated or low-molecular-weight heparin throughout pregnancy - this is the only treatment for RPL with strong evidence of benefit. Live birth rates improve from ~10-20% (no treatment) to 70-80%.

Endocrine Treatment

Hypothyroidism / subclinical hypothyroidism: Levothyroxine to maintain TSH <2.5 mIU/mL in first trimester.
Hyperprolactinemia: Bromocriptine or cabergoline to normalize levels.
PCOS/insulin resistance: Metformin may be considered; evidence insufficient for routine use.
Strict glycemic control in women with diabetes.

Progesterone Supplementation

Vaginal progesterone is widely used in clinical practice. The PROMISE trial showed no benefit in unexplained RPL; however, the PRISM trial (n>4000) suggested possible benefit in women with early pregnancy bleeding. Current consensus: reasonable to use in clinical practice but not strongly evidence-based for unexplained RPL.

Psychological Support

Strong evidence that dedicated support programs with early ultrasound monitoring (the "tender loving care" model) significantly improve live birth rates in unexplained RPL - independent of any specific treatment.
Close monitoring with serial beta-hCG and ultrasound in subsequent pregnancy.

Interventions of Unproven/No Benefit

Leukocyte immunization therapy
Paternal lymphocyte immunization
IVIG alone
Routine anticoagulation for inherited thrombophilias without thrombotic history

Prognosis

Even without treatment, prognosis is better than many patients believe:

After 3 losses: ~55-75% chance of next live birth (age-dependent)
After 5 losses: ~40-55%
Prognosis worsens significantly with advanced maternal age and increasing number of losses

Recent Guidelines (2024-2025)

Australasian ACCEPT 2024 (PMID 38934293) - two-part guideline covering investigation and management
SOGC Guideline No. 464, 2025 (PMID 41176277) - Canadian practice guideline updated
APS in pregnancy, 2025 (PMID 40128683) - comprehensive review confirming aspirin + LMWH as standard of care

Sources: Berek & Novak's Gynecology, Ch. 33 (Recurrent Pregnancy Loss); Creasy & Resnik's Maternal-Fetal Medicine, Ch. 41; Australasian ACCEPT Guidelines 2024; SOGC Guideline No. 464, 2025.

Phecomelia causes

Phocomelia is a rare limb reduction defect where the proximal limb segments (upper arm/thigh) are absent or severely shortened, causing the hands or feet to attach directly to the trunk (like a seal's flipper). The most notorious cause is thalidomide (a sedative/antiemetic used in the late 1950s-early 1960s). Other causes include genetic syndromes and other teratogens.

Searching sources...

Reading File

Finding Sources

Searching the Web

phocomelia causes thalidomide genetic syndromes teratogen mechanism

Good hits. Now let me read the key textbook sections in parallel.

Reading File

Let me also get the radiology section and fetch the teratogen timeline image.

Reading File

Loading Image

I also want the phocomelia X-ray image and the thalidomide mechanism section.

Loading Image

Finding Sources

I now have comprehensive information to give a complete answer. Here it is:

Phocomelia - Causes

The term phocomelia (from Greek phoke = seal, melos = limb) describes a congenital malformation in which the proximal limb segments (humerus, femur) are absent or severely shortened, so that the hand or foot appears to attach directly at the shoulder or hip - resembling a seal's flipper.

Here is an X-ray demonstrating thalidomide-induced phocomelia of the right upper limb (hand attached near the shoulder, no humerus or forearm):

Phocomelia X-ray - hand arising near shoulder with absent humerus

Fig. 73.46 Phocomelia - upper limb anomalies secondary to toxic effects of thalidomide. (Grainger & Allison's Diagnostic Radiology)

Causes

1. Thalidomide (most notorious/classical cause)

Thalidomide was a sedative and antiemetic prescribed to pregnant women in the late 1950s-early 1960s, primarily in West Germany and the UK. It caused a catastrophic epidemic of phocomelia:

60% of infants born to mothers who took thalidomide between days 38 and 54 after conception developed this deformity.
The critical window is weeks 4-7 of gestation - exactly when the arms and legs are forming (see developmental timeline below).
The anomaly was previously extremely rare (0.8% of all congenital hand malformations) but became common during the thalidomide epidemic.
Thalidomide was withdrawn from the market in 1961 precisely because of these effects.

Mechanism of thalidomide teratogenicity (multifactorial):

Anti-angiogenic effect - thalidomide inhibits new blood vessel formation (VEGF-mediated angiogenesis), destroying the immature capillary network supplying the developing limb bud
Oxidative stress - generates reactive oxygen species that damage DNA in limb bud cells
Cereblon binding - thalidomide binds the E3 ubiquitin ligase substrate receptor CRBN, disrupting the ubiquitination and degradation of transcription factors (SALL4, IKZF1/3) critical for limb development
FGF/Wnt signaling disruption - interferes with fibroblast growth factor signaling essential for limb outgrowth

The critical teratogenic window for limb development (weeks 4-7):

Critical periods of human development - teratogen sensitivity by organ

Schematic of critical periods of human development - arms and legs are maximally sensitive to teratogens during weeks 4-7. (Katzung's Basic & Clinical Pharmacology, 16th Ed.)

2. Genetic Syndromes

Several genetic syndromes list phocomelia as a feature. The key ones include:

Syndrome	Inheritance	Key Features
Roberts syndrome	Autosomal recessive	Phocomelia of all 4 limbs, cleft lip/palate, prenatal growth retardation, chromosomal heterochromatin repulsion (ESCO2 gene mutation)
SC phocomelia syndrome	Autosomal recessive	Variant of Roberts syndrome; milder limb reduction, corneal clouding, hemangiomas
Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome	Autosomal recessive	Severe limb reduction + genitourinary/cardiac defects (WNT7A gene)
Grebe syndrome	Autosomal recessive	Severe acromesomelic shortening of limbs (CDMP1/GDF5 gene)
Cornelia de Lange syndrome	Autosomal dominant (NIPBL mutations)	Limb reduction defects including phocomelia in severe forms, distinctive facies, growth retardation
Fuhrmann syndrome	Autosomal recessive	Aplasia/hypoplasia of fibula, femoral bowing, poly/oligodactyly
Holt-Oram syndrome	Autosomal dominant (TBX5 gene)	Radial ray defects, atrial/ventricular septal defects
Fanconi anemia	Autosomal recessive	Radial ray hypoplasia, aplastic anemia, cancer predisposition

Also associated with chromosomal anomalies: trisomy 18, trisomy 13, and other aneuploidies.

3. Other Teratogens (rare reports)

Misoprostol (prostaglandin E1 analog used as an abortifacient) - associated with limb reduction defects including transverse deficiencies
Cocaine - vasoconstriction causing limb ischemia
Maternal diabetes - associated with various limb defects (caudal regression, limb reduction)
Warfarin embryopathy - stippled epiphyses and nasal hypoplasia; occasionally limb defects
Organic solvents / environmental exposures - weak evidence

4. Vascular Disruption Sequence

Isolated (sporadic) phocomelia may result from a vascular disruption event in utero - an interruption of blood supply to the developing limb bud leading to tissue infarction and resorption. This can occur without a teratogen or identifiable genetic cause.

Associated Features (non-thalidomide phocomelia)

Half of all patients with phocomelia have additional anomalies:

Radial ray deficiencies
Cleft lip and palate (especially Roberts syndrome)
Scoliosis
Cardiac defects
Skin and calcification aberrations
Chromosomal abnormalities

Anatomically, the clavicle and scapula are always present. There is no true elbow joint, and the hand typically has only 3-4 digits with an absent thumb.

Classification (Frantz & O'Rahilly)

Type	Description
Complete phocomelia	All proximal and intermediate limb bones absent - hand/foot directly on trunk
Proximal phocomelia	Proximal bone (humerus/femur) absent - forearm/leg + hand/foot present
Distal phocomelia	Intermediate bone (radius-ulna/tibia-fibula) absent - hand/foot attached to humerus/femur

Summary of causes - mnemonic TGVI:

Thalidomide (classic teratogen, critical window weeks 4-7)
Genetic syndromes (Roberts, SC phocomelia, Al-Awadi, Cornelia de Lange, etc.)
Vascular disruption (sporadic in utero ischemia)
Idiopathic / chromosomal (trisomies, unclassified)

Sources: Campbell's Operative Orthopaedics 15th Ed 2026, Ch. 85; Katzung's Basic & Clinical Pharmacology 16th Ed, Ch. 59; Grainger & Allison's Diagnostic Radiology, Ch. 73

Placenta and cord disorders

Placental and cord disorders are a major category in obstetrics and perinatal pathology. Key placental disorders include placenta previa, placental abruption, placenta accreta spectrum, and molar pregnancy. Cord disorders include velamentous insertion, vasa previa, nuchal cord, and true/false knots. Let me pull comprehensive textbook content on all of these.

Searching sources...

Reading File

Finding Sources

Searching the Web

placenta and cord disorders obstetrics overview classification 2024

Let me search more specifically in the library.

Finding Sources

Now let me read the main content sections in parallel.

Reading File

Excellent content. Now let me read the accreta/percreta section and the cord pathology section in parallel.

Reading File

Excellent rich content. Let me also read the accreta/abruption from the radiology book and Creasy's abruption section, plus fetch the PAS ultrasound image.

Reading File

Loading Image

I now have comprehensive, well-sourced content across all major categories. Let me compile the full answer.

Placenta and Cord Disorders

PART A: PLACENTAL DISORDERS

1. Placenta Previa

Definition: Implantation of the placenta over or adjacent to the internal cervical os.

Classification (current terminology - "partial/marginal/complete" are no longer standard):

Low-lying placenta - placental edge is within 2 cm of the internal os but does not cover it
Placenta previa - placenta covers the internal os (formerly called "complete" or "total" previa)
If the placental edge is ≤1 cm from the os or covers it, caesarean section is generally recommended

Incidence: ~1 in 200-250 pregnancies

Risk factors:

Advanced maternal age
Multiparity
Prior caesarean section / uterine surgery
Prior placenta previa
Uterine abnormalities
Multiple gestation
Tobacco use

Clinical features:

Painless, bright-red vaginal bleeding in the second/third trimester - classic presentation
Average first bleed at 27-32 weeks
~20% have some uterine irritability
Abnormal fetal lie (transverse, breech) due to lower uterine placenta
Bleeding is initially self-limited but recurs; central previa can cause exsanguination

Important: Digital or instrumental cervical examination is absolutely contraindicated until placenta previa is excluded by ultrasound - it can precipitate catastrophic hemorrhage.

"Placental migration": 90% of second-trimester previas diagnosed on US resolve by term as the lower uterine segment elongates, drawing the placenta away from the os. Only ~20% of previas reaching term are central/complete.

Diagnosis:

Transvaginal ultrasound (TVUS) - preferred, safe, most accurate
Transabdominal US - 93-98% accurate; empty bladder required (full bladder over-diagnoses previa)
MRI - useful in equivocal cases or when PAS is suspected

Management:

Immediate obstetric consultation; two large-bore IV lines, fluid resuscitation
Continuous fetal monitoring
CBC, coagulation studies (fibrinogen <300 mg/dL = significant coagulopathy), type and crossmatch
Rh-negative patients: Rh immune globulin 300 µg within 72 hours
Expectant management if not in labor and hemodynamically stable
Caesarean delivery if persistent, bleeding, or at term

2. Placental Abruption (Abruptio Placentae)

Definition: Premature separation of a normally implanted placenta from the uterine wall before delivery of the fetus.

Incidence: ~1% of pregnancies; most frequent between 24-26 weeks

Risk factors:

Hypertension (most common)
Trauma (including domestic violence)
Advanced maternal age
Cocaine/tobacco use
Prior abruption
Preterm premature rupture of membranes

Types by bleeding pattern:

Type	Description
Revealed (external)	Blood escapes through the cervix - visible vaginal bleeding
Concealed	Blood collects behind the placenta, no external bleeding; may be more severe
Mixed	Elements of both

Clinical features:

Painful vaginal bleeding (contrast with previa = painless)
Uterine tenderness and rigidity ("woody" uterus)
Fetal distress or intrauterine fetal death
Coagulopathy/DIC (especially concealed abruption with large retroplacental clot)
Couvelaire uterus (uterine apoplexy) - hemorrhage dissects into myometrium

Diagnosis:

Primarily clinical - USS has only 25% sensitivity for abruption; ultrasound cannot exclude abruption
US may show retroplacental hematoma (if zone >2 cm, suspicious)
CT: full-thickness areas of low attenuation making an acute angle with the myometrium
MRI: more accurate than US, limited routine use

Management:

Hemodynamic stabilization
Emergency caesarean if fetal distress or maternal instability
Coagulopathy correction (FFP, cryoprecipitate, platelets)
Monitor for DIC
Kleihauer-Betke test for feto-maternal hemorrhage

3. Placenta Accreta Spectrum (PAS)

Abnormal invasion of placental villi into the myometrium due to deficient decidua basalis. PAS is not homogeneous - foci of accreta, increta, and percreta can coexist in the same placenta.

Graded spectrum:

Type	Definition	Histology
Placenta accreta	Placenta and myometrium in direct contact (no decidua)	Villi attached directly to superficial myometrium
Placenta increta	Placenta invades into the myometrium	Villi penetrate myometrial fibres
Placenta percreta	Placenta breaches uterine serosa; may invade bladder, bowel	Villi penetrate through serosa

Risk factors:

Previous caesarean section (most important - risk rises with each CS)
Placenta previa overlying a uterine scar
Prior myomectomy or uterine curettage
Advanced maternal age

Mortality: Overall 3%; rises to 20% if bladder is involved (percreta). Leading causes of death: massive hemorrhage, DIC.

Ultrasound features (sensitivity 90.7%, specificity 96.9%):

PAS Type	Key US Feature
Accreta	Bridging vessels (71%), "tornado vessels" with multidirectional flow
Increta	Loss of retroplacental clear zone (62-85%)
Percreta	Placental lacunae (82%) ± turbulent flow; subplacental hypervascularity; bladder-uterine interface irregularity

Placenta Accreta Syndrome - Ultrasound and MRI

Fig. 35.53 - (A) Transvaginal US showing irregularity of the uterine-placental interface (white arrows) indicating PAS. (B) Sagittal T2 MRI showing low-lying placenta with low T2 placental bands (black arrow) and myometrial irregularity consistent with placenta increta (white arrow). (Grainger & Allison's Diagnostic Radiology)

MRI features: Heterogeneous placental signal; uterine bulge with myometrial thinning <1 mm or focal interruption; low T2 intraplacental bands; disorganized placental vasculature; bladder tenting or invasion. MRI is preferred when posterior placenta or US is inconclusive.

Management:

Pre-delivery diagnosis allows planned caesarean hysterectomy (reduces morbidity/mortality)
Temporary aortic or iliac artery balloon occlusion during surgery
Multidisciplinary team: maternal-fetal medicine, urology, interventional radiology, blood bank
Minimally invasive accreta may be removed manually/by curettage; increta/percreta usually require hysterectomy

4. Vasa Previa

Definition: Fetal blood vessels unsupported by the umbilical cord or placental tissue traverse the fetal membranes over the internal cervical os, lying below the presenting fetal part.

Association: Almost always coexists with velamentous cord insertion; also associated with bilobed or succenturiate-lobed placentas where vessels run between lobes.

Risk: When membranes rupture (spontaneously or artificially), these unprotected vessels tear → acute fetal exsanguination. Fetal mortality 33-100% if undiagnosed.

Diagnosis:

Color Doppler US: hypoechoic vessels overlying internal os with flow on Doppler; they do not change position with maternal repositioning (differentiates from a cord loop)
Clinically: pulsatile vessels palpated ahead of presenting part on digital exam; sinusoidal FHR pattern after membrane rupture; APH with sudden fetal bradycardia

Management:

Elective caesarean section before labor at 35-36 weeks if diagnosed antenatally
Emergency caesarean if membranes rupture with vasa previa - immediate neonatal resuscitation and transfusion

5. Molar Pregnancy / Gestational Trophoblastic Disease

(Covered separately - involves abnormal placental villous development)

6. Retained Products of Conception (RPOC)

Residual placental tissue remaining in the uterine cavity after miscarriage, termination, or delivery - especially with abnormal placental morphology or unsuspected PAS.

Complications: Postpartum hemorrhage, infection, Asherman syndrome
US: Heterogeneous echogenic mass with vascularity on Doppler (vs. intrauterine hematoma which is avascular)
CT: Heterogeneous enhancing mass in uterine cavity
Management: Surgical evacuation (suction curettage) or medical management (misoprostol)

PART B: UMBILICAL CORD DISORDERS

Cord abnormalities account for 10% of stillbirths.

1. Abnormal Cord Insertion

Type	Definition	Incidence	Clinical Significance
Normal (central)	Inserts on the central portion of the placenta	~80%	-
Marginal (battledore)	Inserts within 2 cm of placental edge	<10% singletons; 25-33% twins	Generally benign; FGR risk
Velamentous	Cord inserts on the fetal membranes; vessels travel unprotected through membranes before entering placenta	1% singletons; 15% monochorionic twins	Hemorrhage, FGR, vasa previa
Furcate	Vessels lose Wharton's jelly protection before entering chorionic plate; they splay widely	Rare	Exposed vessels susceptible to trauma, rupture, torsion, and stillbirth

Velamentous insertion is the most clinically dangerous cord insertion anomaly - the unprotected membrane vessels are susceptible to compression, rupture, and vasa previa formation.

2. Cord Prolapse

Definition: The umbilical cord presents in advance of the fetal presenting part after rupture of membranes (overt prolapse) or lies alongside the presenting part (occult prolapse).

Risk factors:

Abnormal fetal presentation (breech, transverse)
Prematurity
Multiparity
Polyhydramnios
Obstetric manipulation (amniotomy, version)
Abnormally long umbilical cord

Clinical features: Cord visible/palpable at or outside the cervix; sudden severe fetal bradycardia after membrane rupture

Management: Obstetric emergency - relieve cord compression by manually elevating the presenting part, position mother in knee-chest or Trendelenburg, urgent caesarean delivery.

3. Nuchal Cord

Cord wrapped around the fetal neck
Occurs in up to 30% of uncomplicated deliveries (single nuchal cord in 23.6%, multiple cords in 3.7%)
Generally not an independent cause of stillbirth - isolated nuchal cord at birth without histopathologic evidence of cord occlusion is insufficient to attribute adverse outcome to it
Tight nuchal cord with evidence of cord occlusion, fetal hypoxia, and histopathologic thrombosis is a recognized cause of perinatal death

4. True Knots

Occur when the fetus passes through a loop of cord
More common with long cords, polyhydramnios, active fetuses
Common incidentally at birth; a "tight" knot causing stillbirth should show grooving of the cord, constriction of vessels, edema, congestion, or thrombosis to be considered causative
Isolated finding of a true knot at birth is insufficient to diagnose cord accident as cause of stillbirth without pathologic evidence of occlusion

5. Cord Torsion

Most often at the fetal end of the cord
Pathological torsion: congested, edematous cord, often with thrombosis of cord vessels
Can cause fetal death

6. Cord Hematoma, Stricture, and Rupture

Hematoma: Usually at fetal end; spontaneous or traumatic; associated with FGR and fetal death
Stricture: Focal narrowing of cord; rare; associated with torsion and fetal death
Rupture: Extremely rare; associated with abnormally short/long cords or varices; can cause rapid fetal exsanguination

7. Single Umbilical Artery (Two-Vessel Cord)

Normal cord has 2 arteries + 1 vein
Single umbilical artery occurs in ~1% of pregnancies
Associated with congenital anomalies (renal, cardiac, chromosomal), FGR
Isolated finding (no other anomalies on detailed scan) carries low risk

Summary Table

Condition	Key Feature	Classic Presentation	Main Risk
Placenta previa	Placenta over os	Painless antepartum bleeding	Hemorrhage, emergency CS
Placental abruption	Premature separation	Painful APH + uterine rigidity	DIC, fetal death
Placenta accreta	Absent decidua, myometrial attachment	Retained placenta at delivery	Catastrophic PPH
Placenta increta	Myometrial invasion	As above	PPH, hysterectomy
Placenta percreta	Serosal/bladder breach	As above + organ invasion	20% maternal mortality if bladder
Vasa previa	Vessels over os in membranes	APH + sudden fetal bradycardia at ROM	33-100% fetal mortality
Velamentous cord	Vessels in membranes	FGR, vasa previa	Hemorrhage, stillbirth
Cord prolapse	Cord ahead of presenting part	Bradycardia after ROM	Fetal asphyxia
True knot (tight)	Cord knot with vessel constriction	Usually found at delivery	Stillbirth
Single umbilical artery	1 artery + 1 vein	Incidental on US	Fetal anomalies, FGR

Sources: Rosen's Emergency Medicine 10th Ed, Ch. on Antepartum Hemorrhage; Creasy & Resnik's Maternal-Fetal Medicine, Ch. 41 (Umbilical Cord Pathology); Grainger & Allison's Diagnostic Radiology, Ch. 35 (Placenta & Cord); Textbook of Family Medicine 9th Ed, Ch. 20

Battledore placenta

Battledore placenta refers to a marginal cord insertion - where the umbilical cord inserts at the very edge (margin) of the placenta, resembling a battledore (an old paddle-shaped racket used in badminton). It occurs in about 7-9% of singleton pregnancies. It is generally considered a benign variant but may be associated with FGR and preterm delivery.

Searching sources...

Finding Sources

Searching the Web

battledore placenta marginal cord insertion clinical significance complications

Finding Sources

Good - I have image URLs and file locations. Let me read the key sections and fetch the ultrasound images in parallel.

Reading File

Loading Image

Now let me read the detailed Creasy & Resnik chapter on cord insertion types and clinical management.

Reading File

I now have all the content needed. Let me also read the key clinical findings section just before management.

Reading File

I have thorough information. Here is the complete answer:

Battledore Placenta

Definition and Etymology

Battledore placenta is a placenta with marginal cord insertion - the umbilical cord inserts at or within the margin (edge) of the placenta, rather than in the center. The name comes from the resemblance to a battledore - the old paddle-shaped racket used in early badminton - where the placenta is the paddle and the cord is the handle attached at its edge.

The term marginal insertion is formally defined as cord insertion within 2 cm of the placental edge (but the cord still enters the placental disc, not the membranes beyond it - which would be velamentous insertion).

Comparison of Cord Insertion Types

Type	Definition	Incidence (Singleton)	Clinical Risk
Central	Inserts into central portion of disc	~80%	Lowest
Eccentric	Inserts off-center but >2 cm from edge	~10%	Minimal
Marginal (Battledore)	Inserts within 2 cm of placental edge	7-10%	Mild
Velamentous	Cord inserts into membranes beyond placental edge	1-3%	High (vasa previa risk)

Ultrasound Appearance

The cord insertion site is identified using color Doppler and gray-scale imaging in two right-angle planes. In battledore placenta, the vessels are seen arriving at the very margin of the placental disc.

Sagittal view - marginal cord insertion (battledore):

Marginal cord insertion - sagittal ultrasound showing vascular structure at upper placental margin

Figure 27.3 - Sagittal view of the posterior placenta showing a vascular structure near the upper placental margin. (Creasy & Resnik's Maternal-Fetal Medicine)

Color Doppler - marginal cord insertion:

Color Doppler showing umbilical cord insertion at the placental margin

Figure 27.4 - Color Doppler image demonstrating umbilical cord insertion at the placental margin. (Creasy & Resnik's Maternal-Fetal Medicine)

Key differential from velamentous insertion: To confirm marginal (not velamentous) insertion, there should be no segment of umbilical vessels traveling through the fetal membranes beyond the placental edge. If at least 1 cm of vessels are seen traveling in the membranes beyond the edge, the diagnosis is velamentous, not marginal.

Incidence

Singletons: <10% (approximately 7-9%)
Twin gestations: 20-33% - significantly higher, especially in the smaller of the twins (the smaller twin typically has the peripheral - marginal or velamentous - insertion)
More common when there is placenta previa

Pathogenesis

The developmental dynamics governing where the umbilical vessels insert as the placental disc expands are poorly understood. Based on first-trimester ultrasound observations, the cord insertion position appears to be established very early in pregnancy. Differential growth of the placental disc may result in a cord that was originally more central becoming relatively marginal over time.

Clinical Significance

Generally Favorable Prognosis

Central and marginal (battledore) cord insertion have no established association with abnormal fetal outcome when occurring in isolation in singleton pregnancies. Creasy & Resnik's states directly: "Central and marginal PCI have no associations with abnormal fetal outcome."

Potential Associations (mild/context-dependent)

Fetal growth restriction (FGR) - marginal insertion is associated with slightly reduced placental efficiency; the smaller twin with peripheral cord insertion in discordant twins shows this most clearly
Preterm premature rupture of membranes (PPROM) and preterm birth - velamentous and, to a lesser extent, marginal cord insertions are associated with increased risk of PROM, preterm PROM, and preterm birth
Postpartum hemorrhage - marginal umbilical cord insertion is listed as a risk factor for PPH (Tintinalli's Emergency Medicine)
Fetal distress in labor - some association reported, though weak in isolation
Cord prolapse - theoretically higher risk if cord is eccentric/marginal with less secure anchoring

NOT associated with:

Fetal structural anomalies
Vasa previa (this is a risk of velamentous insertion, not marginal - an important distinction)

Differentiating Battledore from Velamentous Insertion

This distinction is clinically important because velamentous insertion carries a much higher risk:

Feature	Battledore (Marginal)	Velamentous
Cord entry point	At the placental disc edge	Into the fetal membranes, beyond disc edge
Vessels in membranes	No (or <1 cm)	Yes - vessels travel unprotected in membranes
Wharton's jelly protection	Present up to the placenta	Lost in the membrane segment
Vasa previa risk	No	Yes (if vessels overlie internal os)
FGR risk	Mild	Moderate
Fetal mortality risk	Minimal	High if vasa previa ruptures

Management

Battledore placenta in isolation (singleton): No specific obstetric intervention required beyond standard care. Normal mode of delivery is appropriate.
Serial growth ultrasounds are indicated when marginal insertion occurs in twin gestations (where growth discordance is more likely).
Exclude vasa previa: When marginal or peripheral cord insertion is found, color Doppler should confirm that no vessels course across the internal cervical os.
At delivery: Be aware of potential cord avulsion during placental delivery (applies more to velamentous than marginal, but relevant with any peripheral insertion).

Summary

Battledore placenta (marginal cord insertion) is a common, usually benign anatomical variant where the umbilical cord attaches at the edge of the placenta. It is clinically significant mainly in the context of twin pregnancies (contributing to growth discordance) and as a risk factor for postpartum hemorrhage and preterm birth. It does not carry the high-risk implications of velamentous insertion or vasa previa. The diagnosis is made on ultrasound using color Doppler, and the key clinical task is to distinguish it from velamentous insertion and confirm the absence of vasa previa.

Sources: Creasy & Resnik's Maternal-Fetal Medicine, Ch. 27 (Marginal and Velamentous Umbilical Cord Insertion); Grainger & Allison's Diagnostic Radiology, Ch. 35 (Table 35.4 - Anomalous Cord Insertions); Tintinalli's Emergency Medicine (Table 101-7 - PPH Risk Factors)

This is a shared conversation. Sign in to Orris to start your own chat.